Sign in
4

Changes in Ownership

Monte Rosa Therapeutics, Inc. Filed Acc 0001193125-26-002389

President & CEO sold 10,135 shares at $15.17 ($153,748)

  • President & CEO acquired 90,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Warmuth Markus · President & CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-01-02 Grant or award : show line 1 in the form +90,000 634,538 D
2026-01-05 Sale : show line 2 in the form −10,135 $15.17 $153,748 624,403 D
Open-market sales · 10,135 sh · avg $15.17 · $153,748

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-01-02 Grant or award : show line 3 in the form Stock Option (Right to Buy) +406,000 406,000 D
Loading xslF345X05/ownership.xml…